Gadolinium-dependent distinction brokers (GBCAs) are widely Employed in magnetic resonance imaging (MRI) to improve the visibility of blood vessels, tumors, inflammation, as well as other internal buildings. When commonly regarded Risk-free, considerations about GBCA toxicity have emerged in the last 20 years—specifically in patients with impaire